Newsquawk Logo

[MARKET ANALYSIS] European equities start the last day of Q2 entirely in the green

Newsquawk StaffPublished On the live feed at — 18 more headlines followed before this page went public
Newsquawk headlinesUTC

German Brandenburg CPI YoY (Jun) Y/Y 2.4% (Prev. 2.8%)

German North Rhine Westphalia CPI MoM (Jun) M/M -0.4% (Prev. -0.2%)

[MARKET ANALYSIS] European equities start the last day of Q2 entirely in the green

Emirates NBD is reportedly holding talks to acquire HSBC's (HSBA LN) Turkish unit

Polish Inflation Rate MoM Prel (Jun) M/M -0.5%

Open the platform and use it. The whole workspace is free to try, with no signup and no card. When you want the headlines arriving live instead of on a delay, Newsquawk Pro is £24.99 for 7 days.

Try the platform free
Free. No signup, no card.
  • European bourses (STOXX 600 +0.6%) begin the last day of Q2 entirely in the green, with outperformance in the DAX 40 (+0.9%) and AEX (+0.5%). Many indices are set to have their biggest quarterly gain since the end of 2022, with the STOXX 600 just shy of 10% gains for Q2. Focusing on Germany's DAX, analysts see possible continued underperformance, with any flare-up in EU-China tensions posing a further headwind. Its auto sector has been particularly affected in recent months, with China playing a key role in that narrative.
  • Sectors highlight the positive bias. Basic Resources (+2.1%), Technology (+1.3%) and Industrial Goods & Services (+1.4%) are the outperformers, while Consumer Products & Services (-0.7%), Food, Beverages & Tobacco (-0.6%) and Autos (-0.6%) are the only sectors printing modest losses.
  • A lot of pharma updates this morning: Abivax (+25.5%), its experimental UC drug helped harder-to-treat groups of patients achieve remission; Sanofi (+0.2%), its Nexviazyme met all primary and secondary endpoints in infantile-onset Pompe disease phase 3 study; Genmab (+7.6%), its phase 3 study for epcoritamab + lenalidomide met its primary objective.
  • Other key stories today: Maersk (-0.6%), despite raising its FY EBITDA guidance citing strong Asia demand; Sainburys (+2.1%), backed its FY guidance after reporting Q1 sales growth of 3.1%; easyJet (-0.8%), downgraded by RBC, Citi and UBS, with UBS citing uncertainty around a solid offer from Castlelake.
  • US equity futures are also firmer across the board, with the NQ's Q2 gains in excess of 24%. The tech/AI story has been the key part of the move higher in recent months and is set to remain a key fundamental driver in the coming months.

Related headlines

The whole workspace, free to try.

Try it free
Newsquawk Logo

© 2026 Newsquawk. All rights reserved.